Literature DB >> 12213795

Preventing clinical heart failure: the rationale and scientific evidence.

D A Wood1.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12213795      PMCID： PMC1876271          DOI： 10.1136/heart.88.suppl_2.ii15

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  14 in total

1.  The scope for cardiovascular disease risk factor intervention among people with diabetes mellitus in England: a population-based analysis from the Health Surveys for England 1991-94.

Authors:  H M Colhoun; W Dong; M T Barakat; H M Mather; N R Poulter
Journal:  Diabet Med       Date:  1999-01       Impact factor: 4.359

2.  Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators.

Authors:  P Vantrimpont; J L Rouleau; C C Wun; A Ciampi; M Klein; B Sussex; J M Arnold; L Moyé; M Pfeffer
Journal:  J Am Coll Cardiol       Date:  1997-02       Impact factor: 24.094

3.  Coronary artery disease as the cause of incident heart failure in the population.

Authors:  K F Fox; M R Cowie; D A Wood; A J Coats; J S Gibbs; S R Underwood; R M Turner; P A Poole-Wilson; S W Davies; G C Sutton
Journal:  Eur Heart J       Date:  2001-02       Impact factor: 29.983

4.  The incidence and prevalence of congestive heart failure in Rochester, Minnesota.

Authors:  R J Rodeheffer; S J Jacobsen; B J Gersh; T E Kottke; H A McCann; K R Bailey; D J Ballard
Journal:  Mayo Clin Proc       Date:  1993-12       Impact factor: 7.616

5.  Cardiac transplantation.

Authors:  N E Shumway
Journal:  J Am Coll Cardiol       Date:  1993-07       Impact factor: 24.094

6.  The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease.

Authors:  J Kjekshus; T R Pedersen; A G Olsson; O Faergeman; K Pyörälä
Journal:  J Card Fail       Date:  1997-12       Impact factor: 5.712

7.  Survival of patients with a new diagnosis of heart failure: a population based study.

Authors:  M R Cowie; D A Wood; A J Coats; S G Thompson; V Suresh; P A Poole-Wilson; G C Sutton
Journal:  Heart       Date:  2000-05       Impact factor: 5.994

8.  A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.

Authors:  L Køber; C Torp-Pedersen; J E Carlsen; H Bagger; P Eliasen; K Lyngborg; J Videbaek; D S Cole; L Auclert; N C Pauly
Journal:  N Engl J Med       Date:  1995-12-21       Impact factor: 91.245

9.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Authors:  M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

10.  Blood pressure screening, management and control in England: results from the health survey for England 1994.

Authors:  H M Colhoun; W Dong; N R Poulter
Journal:  J Hypertens       Date:  1998-06       Impact factor: 4.844
View more
  5 in total

Review 1.  Therapies to prevent heart failure post-myocardial infarction.

Authors:  Kevin L Thomas; Eric J Velazquez
Journal:  Curr Heart Fail Rep       Date:  2005-12

2.  Sodium tanshinone IIA sulfonate attenuates angiotensin II-induced collagen type I expression in cardiac fibroblasts in vitro.

Authors:  Le Yang; Xiao-Jing Zou; Xiang Gao; Hao Chen; Jin-Long Luo; Zhao-Hua Wang; Qian-Sheng Liang; Guang-Tian Yang
Journal:  Exp Mol Med       Date:  2009-07-31       Impact factor: 8.718

3.  G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis.

Authors:  Michael T Kuhlmann; Paulus Kirchhof; Rainer Klocke; Lekbira Hasib; Jörg Stypmann; Larissa Fabritz; Matthias Stelljes; Wen Tian; Melanie Zwiener; Marcus Mueller; Joachim Kienast; Günter Breithardt; Sigrid Nikol
Journal:  J Exp Med       Date:  2006-01-09       Impact factor: 14.307

4.  Acute Hyperthermia Inhibits TGF-β1-induced Cardiac Fibroblast Activation via Suppression of Akt Signaling.

Authors:  Masatoshi Narikawa; Masanari Umemura; Ryo Tanaka; Takayuki Fujita; Utako Yokoyama; Tomoaki Ishigami; Kazuo Kimura; Kouichi Tamura; Yoshihiro Ishikawa
Journal:  Sci Rep       Date:  2018-04-19       Impact factor: 4.379

Review 5.  Mesenchymal stromal cells: current understanding and clinical status.

Authors:  Husein K Salem; Chris Thiemermann
Journal:  Stem Cells       Date:  2010-03-31       Impact factor: 6.277
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.